NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 409 | +14.6% | 0.00% | – |
| Q2 2022 | $1,000 | -94.7% | 357 | -90.0% | 0.00% | -100.0% |
| Q1 2022 | $19,000 | +35.7% | 3,572 | +234.5% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | +250.0% | 1,068 | +358.4% | 0.00% | +100.0% |
| Q3 2021 | $4,000 | +33.3% | 233 | +48.4% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 157 | +1.9% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 154 | +28.3% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 120 | -59.3% | 0.00% | -100.0% |
| Q3 2020 | $5,000 | -44.4% | 295 | -22.4% | 0.00% | -50.0% |
| Q2 2020 | $9,000 | -62.5% | 380 | -73.2% | 0.00% | -50.0% |
| Q1 2020 | $24,000 | -14.3% | 1,419 | -3.7% | 0.00% | +33.3% |
| Q4 2019 | $28,000 | +27.3% | 1,473 | +12.5% | 0.00% | 0.0% |
| Q3 2019 | $22,000 | -68.1% | 1,309 | -34.6% | 0.00% | -72.7% |
| Q2 2019 | $69,000 | +1280.0% | 2,002 | +994.0% | 0.01% | +1000.0% |
| Q1 2019 | $5,000 | +25.0% | 183 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -55.6% | 183 | +10.9% | 0.00% | -66.7% |
| Q3 2018 | $9,000 | -35.7% | 165 | -49.5% | 0.00% | -40.0% |
| Q2 2018 | $14,000 | -65.0% | 327 | -18.7% | 0.01% | -66.7% |
| Q1 2018 | $40,000 | +263.6% | 402 | +107.2% | 0.02% | +275.0% |
| Q4 2017 | $11,000 | +175.0% | 194 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $4,000 | – | 194 | +88.3% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 103 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $2,000 | +100.0% | 103 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | 0.0% | 103 | -11.2% | 0.00% | 0.0% |
| Q3 2016 | $1,000 | 0.0% | 116 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | 0.0% | 116 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | -83.3% | 116 | -68.0% | 0.00% | -75.0% |
| Q4 2015 | $6,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |